Position in NTRA
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$19,159,483
+$5,143,984 QoQ
Shares Held
70,582
+0.7% QoQ
Ownership
0.049%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#155
of 844 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NTRA Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Vanguard Global Advisers, LLC holds $1,247,651,641 across 36 Diagnostics & Research names. NTRA ranks #12 (1.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
801,663 | $401,921,761 | |
| 2 | DHR |
Danaher Corp /De/
|
1,359,015 | $258,865,177 | |
| 3 | IDXX |
Idexx Laboratories Inc /De
|
170,040 | $89,515,857 | |
| 4 | A |
Agilent Technologies, Inc.
|
609,101 | $80,906,885 | |
| 5 | WAT |
Waters Corp /De/
|
211,870 | $79,459,724 | |
| 6 | IQV |
Iqvia Holdings Inc.
|
359,846 | $69,529,444 | |
| 7 | MTD |
Mettler Toledo International Inc/
|
43,604 | $55,704,546 | |
| 8 | DGX |
Quest Diagnostics Inc
|
240,742 | $51,025,266 |
All Filings in NTRA
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $19,159,483 | 70,582 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $14,015,499 | 70,081 | Shares | Defined | 2026-05-08 | |
| No filing history on record for this holder in this stock. | ||||||